Security key
004225108
ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)
CUSIP: 004225108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 170,504,990
- Total 13F shares
- 169,807,590
- Share change
- -1,712,483
- Total reported value
- $3,663,065,967
- Put/Call ratio
- 41%
- Price per share
- $21.57
- Number of holders
- 308
- Value change
- -$28,402,837
- Number of buys
- 142
- Number of sells
- 177
Report period
Q2 2025
Institutions
308
Top holders
10
ACAD full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
ACADIA PHARMACEUTICALS INC SEC filings
ACADIA PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 004225108
Recent filing periods:
Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
12%
from 13D/G
|
21,366,557
|
$354,898,513 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
3/4/5
|
Company · Director, 10%+ Owner |
25%
|
42,877,916
|
$712,202,185 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.9%
|
15,203,234
|
$252,525,717 | — | 31 Mar 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
5%
|
8,540,117
|
$141,851,343 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.1%
|
6,993,513
|
$116,162,251 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.7%
|
4,680,183
|
$77,737,849 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.7%
|
4,647,816
|
$77,200,224 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.1%
|
3,663,145
|
$60,844,838 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
2,954,513
|
$49,085,337 | — | 31 Mar 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
2,769,828
|
$46,006,843 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
1.6%
|
2,663,925
|
$44,247,794 | — | 31 Mar 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
1.4%
|
2,368,462
|
$39,340,153 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.4%
|
2,349,420
|
$39,023,867 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
2,178,770
|
$36,189,370 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.2%
|
1,977,432
|
$32,845,146 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
1.1%
|
1,852,383
|
$30,768,082 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.97%
|
1,655,370
|
$27,498,099 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.96%
|
1,632,749
|
$27,119,961 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.88%
|
1,500,000
|
$24,915,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.87%
|
1,477,033
|
$24,533,518 | — | 31 Mar 2025 | |
| NORGES BANK |
13F
|
Company |
0.83%
|
1,420,611
|
$23,596,349 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.81%
|
1,375,213
|
$22,842,289 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.76%
|
1,302,230
|
$21,630,041 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.7%
|
1,200,839
|
$19,945,936 | — | 31 Mar 2025 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.67%
|
1,138,094
|
$18,903,752 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.62%
|
1,056,850
|
$17,554,278 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.57%
|
967,500
|
$16,070,175 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
852,845
|
$14,165,755 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.48%
|
816,656
|
$13,564,656 | — | 31 Mar 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.48%
|
815,905
|
$13,552,182 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.47%
|
804,390
|
$13,360,918 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.47%
|
804,119
|
$13,356,417 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.45%
|
760,594
|
$12,633,467 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.44%
|
754,748
|
$12,536,364 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.43%
|
731,576
|
$12,151,478 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.42%
|
720,237
|
$11,963,137 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.41%
|
696,825
|
$11,574,266 | — | 31 Mar 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.39%
|
672,223
|
$11,165,624 | — | 31 Mar 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.38%
|
653,759
|
$10,858,937 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.38%
|
649,379
|
$10,787,000 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.38%
|
649,210
|
$10,783,378 | — | 31 Mar 2025 | |
| GREAT LAKES ADVISORS, LLC |
13F
|
Company |
0.36%
|
612,680
|
$10,176,615 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.34%
|
572,261
|
$9,505,255 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.31%
|
523,029
|
$8,687,512 | — | 31 Mar 2025 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.29%
|
495,084
|
$8,223,345 | — | 31 Mar 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.28%
|
470,338
|
$7,812,314 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.26%
|
434,956
|
$7,417,027 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.25%
|
425,903
|
$7,269,636 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
425,470
|
$7,067,057 | — | 31 Mar 2025 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.24%
|
407,051
|
$6,761,117 | — | 31 Mar 2025 |
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q2 2025
As of 30 Jun 2025,
ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
169,807,590 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, RTW INVESTMENTS, LP, STATE STREET CORP, MORGAN STANLEY, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, and Palo Alto Investors LP.
This page lists
310
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
315
Q2 2025 holders
308
Holder diff
-7
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.